1. A rare case of atypical/anaplastic meningioma with MDM2 amplification. (30th May 2018) Authors: Wylleman, Robbert; Debiec-Rychter, Maria; Sciot, Raf Journal: Rare tumors Issue: Volume 10(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas. (March 2018) Authors: Mariño-Enriquez, Adrián; Lauria, Alexandra; Przybyl, Joanna; Ng, Tony L.; Kowalewska, Magdalena; Debiec-Rychter, Maria; Ganesan, Raji; Sumathi, Vaiyapuri; George, Suzanne; McCluggage, W. Glenn; Nucci, Marisa R.; Lee, Cheng-Han; Fletcher, Jonathan A. Journal: American journal of surgical pathology Issue: Volume 42:Number 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cellular Angiofibroma of the Prostate: A Rare Tumor in an Unusual Location. (1st July 2014) Authors: Wyn, Inez; Debiec-Rychter, Maria; Van Cleynenbreugel, Ben; Sciot, Raf Other Names: Cao Dengfeng Academic Editor. Journal: Case reports in pathology Issue: Volume 2014(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial. (December 2017) Authors: Schöffski, Patrick; Wozniak, Agnieszka; Escudier, Bernard; Rutkowski, Piotr; Anthoney, Alan; Bauer, Sebastian; Sufliarsky, Jozef; van Herpen, Carla; Lindner, Lars H.; Grünwald, Viktor; Zakotnik, Branko; Lerut, Evelyne; Debiec-Rychter, Maria; Marréaud, Sandrine; Lia, Michela; Raveloarivahy, Tiana;... Journal: European journal of cancer Issue: Volume 87(2017) Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial. Issue 6 (June 2018) Authors: Schöffski, Patrick; Sufliarsky, Jozef; Gelderblom, Hans; Blay, Jean-Yves; Strauss, Sandra J; Stacchiotti, Silvia; Rutkowski, Piotr; Lindner, Lars H; Leahy, Michael G; Italiano, Antoine; Isambert, Nicolas; Debiec-Rychter, Maria; Sciot, Raf; Van Cann, Thomas; Marréaud, Sandrine; Nzokirantevye, Axel... Journal: Lancet Issue: Volume 6:Issue 6(2018) Page Start: 431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Current treatment options for dermatofibrosarcoma protuberans. Issue 8 (August 2015) Authors: Rutkowski, Piotr; Debiec-Rychter, Maria Journal: Expert review of anticancer therapy Issue: Volume 15:Issue 8(2015) Page Start: 901 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Downstream and Intermediate Interactions of Synovial Sarcoma-Associated Fusion Oncoproteins and Their Implication for Targeted Therapy. (25th March 2012) Authors: Przybyl, Joanna; Jurkowska, Monika; Rutkowski, Piotr; Debiec-Rychter, Maria; Siedlecki, Janusz A. Other Names: Gronchi Alessandro Academic Editor. Journal: Sarcoma Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. First evidence of treatment efficacy in metastatic carcinoma of the parotid gland with BRD4/NUT translocation. (3rd May 2016) Authors: Vulsteke, Christof; Lurquin, Eveline; Debiec-Rychter, Maria; Gheysens, Olivier; Nuyts, Sandra; Schoenaers, Joseph; Politis, Constantinus; Mebis, Jeroen; Hauben, Esther; Clement, Paul M. Journal: Journal of chemotherapy Issue: Volume 28:Number 3(2016:Jun.) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapy. Issue 1 (January 2015) Authors: Lartigue, Lydia; Neuville, Agnès; Lagarde, Pauline; Brulard, Céline; Rutkowski, Piotr; Tos, Paolo Dei; Wardelmann, Eva; Debiec-Rychter, Maria; Italiano, Antoine; Coindre, Jean-Michel; Chibon, Frédéric Journal: European journal of cancer Issue: Volume 51:Issue 1(2015:Jan.) Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Kit Gene in Endometrial Carcinoma: An Immunohistochemical and Mutational Analysis. Issue 2 (1st January 2011) Authors: Vandenput, Ingrid; Debiec-Rychter, Maria; Capoen, An; Verbist, Godelieve; Vergote, Ignace; Moerman, Philippe; Amant, Frédéric Journal: International journal of gynecological cancer Issue: Volume 21:Issue 2(2011) Page Start: 203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗